Thyroid-uptake nuclear medicine system
Australia TGA ARTG Registered Device · InMed Healthcare Pty Ltd · Mirion Technologies (Capintec) Inc · Class IIa · Started February 03, 2023
Good Name: InMed Healthcare Pty Ltd - Thyroid-uptake nuclear medicine system
- Risk Class
- Class IIa
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- February 03, 2023
- Effective Date
- February 03, 2023
- Country
- United States of America
- Address
- 7 Vreeland Road, Florham Park, NJ, 07932
The nuclear measurement system used for quantifying thyroid uptake, bioassay and wipe test in a clinical environment.
Access comprehensive regulatory information for Thyroid-uptake nuclear medicine system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by InMed Healthcare Pty Ltd, manufactured by Mirion Technologies (Capintec) Inc in United States of America. The device registration started on February 03, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.